Stock listing
PHARM Stock Price, News, Filings & Events — Pharming Group Nv
Selected listing: PHARM · EURONEXT · EUR · NL
This page tracks Pharming Group Nv's PHARM:EURONEXT listing on EURONEXT in EUR for NL, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHARM:EURONEXT. PHARM:EURONEXT is the stock-level entry point for investors researching Pharming Group Nv, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pharming Group NV is a public company listed under the ticker PHARM on the Netherlands stock market. The company has a market capitalization of approximately €894.1 million. Pharming focuses on developing innovative therapies for rare diseases, leveraging advanced biotechnology to improve patient outcomes.
- Ticker
- PHARM:EURONEXT
- Asset type
- Stock
- Market cap
- $833.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- EURONEXT
- Currency
- EUR
Pharming Group Nv PHARM:EURONEXT stock context
This page tracks Pharming Group Nv's PHARM:EURONEXT listing on EURONEXT in EUR for NL, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PHARM:EURONEXT. PHARM:EURONEXT is the stock-level entry point for investors researching Pharming Group Nv, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pharming Group NV is a public company listed under the ticker PHARM on the Netherlands stock market. The company has a market capitalization of approximately €894.1 million. Pharming focuses on developing innovative therapies for rare diseases, leveraging advanced biotechnology to improve patient outcomes.
Latest news from Pharming Group Nv
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
August 4, 2026
Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term...
July 30, 2026
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
July 16, 2026
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
June 4, 2026
Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
June 2, 2026
Pharming Group Nv earnings calls
Pharming Group N.V. (PHAR) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Pharming Group N.V. (PHAR) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Pharming Group N.V. (PHAR) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Pharming Group N.V. (PHAR) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Pharming Group N.V. (PHAR) Q2 2025 Earnings Call
July 31, 2025 · Replay with transcript and chapters
Pharming Group N.V. (PHAR) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Pharming Group Nv
Pharming Group Nv investor report
Review AI stock analysis and investor report context for PHARM:EURONEXT.
Pharming Group Nv company profile
View the public company page for Pharming Group Nv on 6ix.
Pharming Group Nv news
Read company news and market updates connected to Pharming Group Nv.
Pharming Group Nv investor events
Find investor webinars, events, and replay context for Pharming Group Nv.
Alternate listings
PHAR:NASDAQ
US · USD
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHARMA:AQUISEU
GB · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
0QCO:LSIN
GB · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHGN:GETTEX
DE · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHARMA:AQUISUK
GB · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHGN:TRADEGATE
DE · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHGN:XETR
DE · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
A1H65A:LSX
DE · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHGUF:OTC
US · USD
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHAR:BOATS
US · USD
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHARMA:TURQUOISE
GB · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.
PHG:GETTEX
DE · EUR
Alternate listing for Pharming Group Nv; the primary context on this page is PHARM:EURONEXT.